Last updated: November 21, 2026
The top biotech and life sciences companies in Hyderabad for 2027 are Bharat Biotech, Biological E, Indian Immunologicals, Aragen Life Sciences and Sai Life Sciences, followed by Aurigene Pharmaceutical Services, Cohance Lifesciences, Vimta Labs, Clonz Biotech and Sanzyme. Bharat Biotech and Biological E are two of the world’s largest vaccine producers, while Aragen, Sai Life Sciences, Aurigene and Cohance are major contract research and manufacturing partners for global drug developers.
Hyderabad is often called the vaccine capital of the world, because companies in and around the city produce a very large share of the world’s vaccine doses. Much of this activity is concentrated in Genome Valley, India’s first and largest life sciences cluster, established in 1999 north of the city. Genome Valley now hosts more than 200 companies from many countries, alongside research institutes, incubators and specialised infrastructure.
This list covers biotech, vaccine and life sciences services companies headquartered or substantially based in Hyderabad. Pharmaceutical generics and API makers are covered separately in our list of pharma companies in Hyderabad. Rankings are editorial, reflecting scale, scientific capability and influence on the cluster, and no company paid to be included.
| Company | Base | Known For | Core Strength |
|---|---|---|---|
| Bharat Biotech | Genome Valley, Hyderabad | Vaccines and biotherapeutics | Global vaccine innovator |
| Biological E | Hyderabad | Vaccines for global public health | One of the world’s largest vaccine producers |
| Indian Immunologicals | Hyderabad | Animal and human vaccines | Major veterinary vaccine maker |
| Aragen Life Sciences | Hyderabad | Drug discovery and development services | Integrated CRO and CDMO |
| Sai Life Sciences | Hyderabad | Small molecule research and manufacturing | CRO and CDMO for innovators |
| Aurigene Pharmaceutical Services | Hyderabad | Contract research, development and manufacturing | CRDMO backed by Dr. Reddy’s |
| Cohance Lifesciences | Hyderabad | API and CDMO services | CDMO and specialty ingredients |
| Vimta Labs | Genome Valley, Hyderabad | Testing and contract research | Testing and clinical research services |
| Clonz Biotech | Genome Valley, Hyderabad | Recombinant biosimilars | Biosimilar manufacturing |
| Sanzyme | Genome Valley, Hyderabad | Probiotics and enzymes | Probiotics and enzyme manufacturing |
Bharat Biotech was founded by Dr. Krishna Ella and is headquartered in Genome Valley, a cluster he helped envision. The company develops and manufactures vaccines and biotherapeutics, and became widely known for Covaxin, India’s indigenous COVID-19 vaccine.
Its portfolio includes vaccines for rotavirus, typhoid, rabies, polio and other diseases, many supplied to public health programmes in developing countries.
Bharat Biotech combines in-house research with large-scale manufacturing, which is rare among vaccine makers in emerging markets.
It remains one of the anchor companies of Hyderabad’s life sciences cluster and a major employer of scientists.
The company has also invested in vaccines for neglected tropical diseases and in new delivery methods, such as intranasal vaccines, which could make immunisation easier in places with limited health infrastructure. Its work during the pandemic raised the global profile of Hyderabad’s vaccine industry.
Biological E is one of India’s oldest pharmaceutical companies, founded in 1953 and headquartered in Hyderabad. It is among the world’s largest producers of vaccines by doses, supplying UNICEF and public health programmes in many countries.
The company developed Corbevax, a COVID-19 vaccine, and has partnered with international companies such as Takeda on vaccines including dengue.
Biological E also makes specialty injectables and other medicines.
Its scale and partnerships make it central to Hyderabad’s reputation as a vaccine capital.
Its partnerships with global companies and foundations show how Hyderabad manufacturers have become essential to international vaccine supply, combining large capacity with the quality systems needed to supply global health agencies.
Indian Immunologicals Limited was set up by India’s National Dairy Development Board and is headquartered in Hyderabad. It is one of the world’s largest producers of foot-and-mouth disease vaccines for animals and also makes human vaccines, including rabies vaccines.
Its veterinary vaccines support India’s livestock sector, which is vital to rural livelihoods.
The company has expanded into human health, including work on new vaccines.
It is an important example of public interest biotechnology in Hyderabad.
Because livestock health affects both farm incomes and food safety, the company’s vaccines play a quiet but important role in India’s rural economy and in controlling diseases that can spread between animals and people.
Aragen Life Sciences, formerly GVK Biosciences, is a Hyderabad-headquartered contract research, development and manufacturing organisation serving pharmaceutical and biotech companies worldwide.
It offers chemistry, biology, biologics development and manufacturing services, helping clients move from early research to clinical supply.
Aragen has announced major expansion plans in Hyderabad, including at Nacharam, to increase capacity.
For global drug developers, it offers integrated services under one roof.
Its biologics capabilities are increasingly important as more new medicines are antibodies and other large molecules. Aragen can support clients from cell line development through to clinical manufacturing, reducing the number of handovers in early development.
Sai Life Sciences is a Hyderabad-headquartered contract research, development and manufacturing organisation focused on small molecule medicines. It works with innovator pharma and biotech companies from discovery through commercial manufacturing.
Sai Life Sciences listed on Indian stock exchanges in 2024 and has expanded research and manufacturing capacity.
Its focus on innovator clients means it works on new medicines rather than generics.
It is one of Hyderabad’s fastest-growing life sciences services companies.
The company has invested in sustainability and digital tools across its labs and plants, and it works with many emerging biotech firms that rely on outsourced partners because they do not have their own manufacturing.
Aurigene Pharmaceutical Services is a contract research, development and manufacturing organisation and a subsidiary of Dr. Reddy’s Laboratories, operating from Hyderabad. It serves pharma and biotech companies with chemistry, biologics and manufacturing services.
Its link to Dr. Reddy’s gives it access to deep manufacturing and regulatory expertise.
Aurigene is part of Genome Valley’s growing services ecosystem.
It suits companies looking for integrated development support.
Cohance Lifesciences is a Hyderabad-based contract development and manufacturing organisation that has combined with Suven Pharmaceuticals, creating a larger platform for pharmaceutical services and specialty ingredients.
It serves innovator and generic companies with process development and manufacturing.
Cohance has a presence in Genome Valley and other sites.
Its scale-up through consolidation makes it a notable player in Hyderabad’s CDMO sector.
Consolidation in contract manufacturing is creating larger Indian platforms that can compete for bigger global projects, and Cohance is one of the Hyderabad companies leading that trend.
Vimta Labs is a Hyderabad-based contract research and testing company with a large life sciences facility in Genome Valley. It provides analytical testing, preclinical and clinical research, and food and environmental testing.
Pharma, biotech, food and medical device companies use Vimta for regulatory testing and research.
Its long history makes it one of the established names in Hyderabad’s life sciences services sector.
Vimta helps companies meet quality and regulatory requirements in India and abroad.
Its Genome Valley campus is one of the larger dedicated life sciences facilities in the cluster, giving clients access to a broad range of testing and research services in one location.
Clonz Biotech was incorporated in 2009 and began operations in Genome Valley in 2010. It focuses on recombinant biosimilars, with a team drawn from leading biosimilar manufacturers.
Biosimilars offer more affordable versions of biologic medicines, which are often very expensive.
Clonz represents the growing biosimilar segment in Hyderabad.
It works with partners for development and commercialisation.
Sanzyme manufactures probiotics, enzymes and related products from an integrated facility in Genome Valley, where it also houses research and development. Its products are registered in more than 30 countries.
Probiotics are a growing market in both medicine and consumer health.
Sanzyme shows the diversity of Hyderabad’s biotech sector beyond vaccines and biologics.
It serves pharmaceutical and nutraceutical companies.
Vaccine and biosimilar makers own products, while CROs and CDMOs provide services to others. Each suits different partners and careers.
Check approvals from WHO, the US FDA, the EMA and Indian regulators, and inspection outcomes.
Look at research publications, patents, pipelines and scientific leadership.
For manufacturing partners, capacity, scale-up capability and quality systems are critical.
Genome Valley offers specialised infrastructure and a dense network of partners and suppliers.
For contract research, ask about confidentiality, data security and IP protection.
For job seekers, training, research opportunities and employee reviews matter.
Expansion announcements, new partnerships and funding signal momentum.
Regulators pay close attention to data integrity in laboratories and plants. Ask about quality management systems, electronic records, audit results and how deviations are investigated and corrected.
We assessed each company on scale, scientific capability, regulatory record, global reach and role in Hyderabad’s life sciences cluster, using company information, public filings and industry sources. Rankings are editorial and no company paid for placement. Read more about how we research and rank.
We gave extra weight to companies with significant research or manufacturing in Hyderabad itself, rather than sales offices, and to those that strengthen the wider cluster through partnerships, training and investment.
Because companies such as Bharat Biotech, Biological E and Indian Immunologicals produce a very large share of the world’s vaccine doses from Hyderabad.
Genome Valley is India’s first and largest life sciences cluster, established in 1999 near Hyderabad, home to more than 200 companies.
A contract research organisation provides research services, such as chemistry, biology or clinical trials, to pharma and biotech companies.
A contract development and manufacturing organisation develops and manufactures medicines for other companies.
Biosimilars are highly similar versions of approved biologic medicines, usually offered at lower prices.
Yes, especially for scientists, quality and regulatory specialists, manufacturing staff and data scientists.
Genome Valley hosts companies from many countries, including Novartis, Ferring and Lonza alongside Indian firms.
Yes. Incubators and shared lab spaces support life sciences startups in and around Genome Valley.
The state promotes life sciences through infrastructure, incentives and initiatives aimed at growing the sector.
Contact business development teams, sign confidentiality agreements, and run a technical evaluation and audit before contracting.
Hyderabad’s biotech and life sciences sector is led by global vaccine producers Bharat Biotech, Biological E and Indian Immunologicals, supported by contract research and manufacturing leaders Aragen, Sai Life Sciences, Aurigene and Cohance, and specialists such as Vimta Labs, Clonz Biotech and Sanzyme.
For partners, the cluster offers something few places can match: vaccine makers, biologics developers, contract research and manufacturing firms, testing labs and specialised suppliers all within a short drive of each other, backed by a deep pool of scientists trained in the city’s pharma and biotech companies.
With Genome Valley continuing to expand, Hyderabad will remain one of the world’s most important life sciences hubs. For related companies, see our list of pharma companies in Hyderabad, our guide to setting up a GCC in Hyderabad, and the Hyderabad hub.